Proportion respondents reporting moderate or severe problems on each EQ-5D dimension; %. by Elin Spege (11378261)

Subjects:

Vasopressin decreased the population fEPSP evoked by stimulation of LIII entorhinal fibers (EC LIII) and recorded in the CA2 dendritic field. by Magda Chafai (295116)

“…AVP (1 min) transiently decreased the LTP-potentiated fEPSP. B) Average graphs (n = 8; values expressed as % of the mean of the responses recorded during 5 min before AVP application) demonstrating that AVP (100 nM; 1 min) transiently and significantly decreased the amplitude of both S1 and S2 fEPSPs without affecting the paired-pulse facilitation (calculated as the ratio S2/S1). …”

Kami-shoyo-san improves ASD-like behaviors caused by decreasing allopregnanolone biosynthesis in an SKF mouse model of autism by Qing-Yun Guo (2007082)

“…On the other hand, the dopamine D₂ receptor antagonist sulpiride and GABA_A receptor antagonist bicuculline only attenuated the ameliorative effect of KSS on repetitive self-grooming behaviors. …”

Treatment with a highly reducing agent decreases ubiquitination of D_4.2R WT and D_{4.2 4KR}R mutant. by Kamila Skieterska (841014)

SMC-specific knockout of Klf5 (smcKlf5^−/−) exacerbates the progression of Ang II–induced AAA by facilitating ROS formation. by Dong Ma (584680)

Subjects:

Excel spreadsheet containing, in separate sheets, the underlying numerical data and statistical analysis for Figs panels 1A, 1D and 1E, 2B and 2D, 3A, 3B, 3C and 3D, 4B, 4D, 4E, 4F... by Jia Shen (1828945)

Data for Fig 5D. by Xiaohua Zhang (350570)

Brain uptake of [¹⁴C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

Cellular uptake of [¹⁴C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

Subjects:

Decrease in CD15⁺ and CD133⁺ expression in Daoy cells under hypoxia condition, upon miR-34a overexpression. by Pasqualino de Antonellis (206257)

GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

Subjects:

Exposure to glucocorticoids decreases the levels of pAMPK and GR in cultured rat prefrontal cortical astrocytes. by Shi-Ying Yuan (2937669)

Cell cycle progression of hMSCs following X-rays irradiation, under normoxia (21% O2) and physioxia (3% O2) growing conditions. by Séverine Cruet-Hennequart (716700)

Subjects:

Percentage decrease in model output peak with the administration of exogenous estrogen/progesterone. by Brenda Lyn A. Gavina (15285185)

ASO treatment suppresses the palbociclib-mediated induction of MEG3 and decrease in cell proliferation in SK-MES-1 cells. by Traci L. Kruer (3342425)

Cisplatin treatment triggered a decrease in PTEN levels and subsequent phosphorylation of key proteins in the PTEN/Akt/FOXO3 pathway. by Eun Mi Chang (837213)

A decrease in ACTH plasma concentration was found over time, while serum cortisol concentrations showed a delayed decrease. by Selma van Staveren (5909135)

R₇-fused peptides inhibit FMDV production in BHK-21 cells. by Mónica González-Magaldi (638526)

Interaction between NP fragment 146–185 and PB2 involves PB2 amino acids 601 to 607. by Ho-Pan Hsia (4768638)

Subjects:

Prolonged starvation leads to a delay in cell cycle re-entry and decrease in H3K27ac in Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

“…Significance levels after one-way ANOVA with Tukey’s HSD for pairwise comparisons are indicated for adjusted <i>p</i> values: *<i>p < </i>0.05, **<i>p < </i>0.01; ****<i>p < </i>0.0001. d: day(s), n.s.: non-significant. See <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s016" target="_blank">S5</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s017" target="_blank">S6 Tables</a> for mean values and statistical data and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s020" target="_blank">S1 Data</a> for individual numerical values.…”